Bailey, R.; Kahoekapu, K.; To, A.; Mayerlen, L.I.; Kae, H.; Manninen, G.; Haun, B.K.; Berestecky, J.M.; Shikuma, C.; Lehrer, A.T.;
et al. Divalent HIV-1 gp120 Immunogen Exhibits Selective Avidity for Broadly Neutralizing Antibody VRC01 Precursors. Vaccines 2026, 14, 58.
https://doi.org/10.3390/vaccines14010058
AMA Style
Bailey R, Kahoekapu K, To A, Mayerlen LI, Kae H, Manninen G, Haun BK, Berestecky JM, Shikuma C, Lehrer AT,
et al. Divalent HIV-1 gp120 Immunogen Exhibits Selective Avidity for Broadly Neutralizing Antibody VRC01 Precursors. Vaccines. 2026; 14(1):58.
https://doi.org/10.3390/vaccines14010058
Chicago/Turabian Style
Bailey, Ryan, Kalista Kahoekapu, Albert To, Ludwig I. Mayerlen, Helmut Kae, Gabriel Manninen, Brien K. Haun, John M. Berestecky, Cecilia Shikuma, Axel T. Lehrer,
and et al. 2026. "Divalent HIV-1 gp120 Immunogen Exhibits Selective Avidity for Broadly Neutralizing Antibody VRC01 Precursors" Vaccines 14, no. 1: 58.
https://doi.org/10.3390/vaccines14010058
APA Style
Bailey, R., Kahoekapu, K., To, A., Mayerlen, L. I., Kae, H., Manninen, G., Haun, B. K., Berestecky, J. M., Shikuma, C., Lehrer, A. T., & MacPherson, I. S.
(2026). Divalent HIV-1 gp120 Immunogen Exhibits Selective Avidity for Broadly Neutralizing Antibody VRC01 Precursors. Vaccines, 14(1), 58.
https://doi.org/10.3390/vaccines14010058
